These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. Abdul-Hussien H, Hanemaaijer R, Kleemann R, Verhaaren BF, van Bockel JH, Lindeman JH. J Vasc Surg; 2010 Jun; 51(6):1479-87. PubMed ID: 20488324 [Abstract] [Full Text] [Related]
4. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm. Lindeman JH, Abdul-Hussien H, Schaapherder AF, Van Bockel JH, Von der Thüsen JH, Roelen DL, Kleemann R. Clin Sci (Lond); 2008 Jun; 114(11):687-97. PubMed ID: 18078385 [Abstract] [Full Text] [Related]
12. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Thompson RW, Baxter BT. Ann N Y Acad Sci; 1999 Jun 30; 878():159-78. PubMed ID: 10415728 [Abstract] [Full Text] [Related]
13. Elastin stabilization for treatment of abdominal aortic aneurysms. Isenburg JC, Simionescu DT, Starcher BC, Vyavahare NR. Circulation; 2007 Apr 03; 115(13):1729-37. PubMed ID: 17372168 [Abstract] [Full Text] [Related]
14. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Chung AW, Yang HH, Radomski MW, van Breemen C. Circ Res; 2008 Apr 25; 102(8):e73-85. PubMed ID: 18388324 [Abstract] [Full Text] [Related]